Year Established :
1973
Total Number of Staff :
more than 1000
Main Competitive Advantages :
Brand Name,International Approvals/Standards,Experienced R&D Staff,Delivery Term,Production Capacity,Large Product Line,Contract Manufacturing (CRO,CMO),Buyers' Specifications Accepted,Small Orders Accepted,Reputation,Quality Service
Other Competitive Advantages :
1) US FDA Approved facilities.
2) Controlled Substances
3) US DMF Available
4) CEP Filed
5) China Registration Available for key API's
6) JDMF Available
Business Type :
Manufacturer
R&D Capacity :
OEM,ODM,Own Brand
Annual Turnover(USD) :
More than 99,999,999
Main Sales Markets :
North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Product Range :
Commercial API's
01 Amlodipine Besylate
02 Apremilast
03 Aripiprazole
04 Azilsartan Kamedoxomil
05 Bempedoic Acid
06 Cannabidiol
07 Dabigatran Etexilate Mesylate
08 Dalfampridine
09 Dimethyl Fumarate
10 Dronedarone
11 Duloxetine Hydrochloride
12 Eluxadoline
13 Eslicarbazepine Acetate
14 Esomeprazole Mg Trihydrate
15 Ezetimibe
16 Lanthanum Carbonate Octahydrate
17 Lurasidone Hydrochloride
18 Mesalamine
19 Nebivolol Hydrochloride
20 Olanzapine
21 Quetiapine Fumarate
22 Rasagiline Mesylate
23 Riluzole
24 Rizatriptan Benzoate
25 Sodium Oxybate
26 Solriamfetol Hydrochloride
27 Tolterodine Tartrate
28 Tolvaptan
Upcoming API's
01 Azilsartan Base
02 Benzonatate HCl
03 Buproprion HCl
04 Mirabegron
05 Rabeprazole Sodium
06 Ticagrelor
Under Development API's
01 Apixaban
02 Candesartan
03 Dapaglifozin
04 Edoxaban Tosylate
05 Empagli?ozin
06 Ivacaftor
07 Minoxidil
08 Olmesartan Medoxomil
09 Sitagliptin Phosphate
10 Solifenacin Succinate